cobas® EBV by Roche

Roche Diagnostics

cobas® EBV by Roche

For accurate monitoring of Epstein-Barr virus (EBV) in transplant patients

FDA Breakthrough Device Designation

Do you know anyone using cobas® EBV by Roche?

The cobas® EBV test is a diagnostic tool used by healthcare professionals to assess the risk of infection in transplant patients. The test is designed to provide reliable, standardized, and high-quality results for improved management of transplant patients. It is intended for use on the automated cobas® 5800/6800/8800 Systems.

The cobas® EBV test has several features and benefits, including standardization, state-of-the-art design, and efficiency, flexibility, and simplicity. The test results are traceable to the WHO International Standard and reported in IU/mL, which improves harmonization in testing results across hospitals and institutions. The test also has a dual-target assay design, which provides reliable and reproducible results, and helps with clinical decision making. Furthermore, the cobas® EBV test can be used to perform critical transplant testing (CMV, EBV, BKV) from a single sample on the cobas® 5800/6800/8800 Systems, with an industry-leading menu, absolute automation and proven performance, which makes the process more efficient and flexible for the healthcare professionals.

cobas® EBV by Roche

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 21, 2024 at 12:56pm